728 related articles for article (PubMed ID: 24243749)
1. NGAL, L-FABP, and KIM-1 in comparison to established markers of renal dysfunction.
Holzscheiter L; Beck C; Rutz S; Manuilova E; Domke I; Guder WG; Hofmann W
Clin Chem Lab Med; 2014 Apr; 52(4):537-46. PubMed ID: 24243749
[TBL] [Abstract][Full Text] [Related]
2. Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients.
Kim SS; Song SH; Kim IJ; Kim WJ; Jeon YK; Kim BH; Kwak IS; Lee EK; Kim YK
Diabetes Metab Res Rev; 2014 Nov; 30(8):736-41. PubMed ID: 24687388
[TBL] [Abstract][Full Text] [Related]
3. Urinary NGAL, KIM-1 and L-FABP concentrations in antenatal hydronephrosis.
Noyan A; Parmaksiz G; Dursun H; Ezer SS; Anarat R; Cengiz N
J Pediatr Urol; 2015 Oct; 11(5):249.e1-6. PubMed ID: 26096437
[TBL] [Abstract][Full Text] [Related]
4. Pre-transplant Evaluation of Donor Urinary Biomarkers can Predict Reduced Graft Function After Deceased Donor Kidney Transplantation.
Koo TY; Jeong JC; Lee Y; Ko KP; Lee KB; Lee S; Park SJ; Park JB; Han M; Lim HJ; Ahn C; Yang J
Medicine (Baltimore); 2016 Mar; 95(11):e3076. PubMed ID: 26986138
[TBL] [Abstract][Full Text] [Related]
5. Role of new biomarkers for predicting renal scarring in vesicoureteral reflux: NGAL, KIM-1, and L-FABP.
Parmaksız G; Noyan A; Dursun H; İnce E; Anarat R; Cengiz N
Pediatr Nephrol; 2016 Jan; 31(1):97-103. PubMed ID: 26324091
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers for early detection of sickle nephropathy.
Sundaram N; Bennett M; Wilhelm J; Kim MO; Atweh G; Devarajan P; Malik P
Am J Hematol; 2011 Jul; 86(7):559-66. PubMed ID: 21630304
[TBL] [Abstract][Full Text] [Related]
7. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy.
Peters HP; Waanders F; Meijer E; van den Brand J; Steenbergen EJ; van Goor H; Wetzels JF
Nephrol Dial Transplant; 2011 Nov; 26(11):3581-8. PubMed ID: 21467131
[TBL] [Abstract][Full Text] [Related]
8. Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus.
Fufaa GD; Weil EJ; Nelson RG; Hanson RL; Bonventre JV; Sabbisetti V; Waikar SS; Mifflin TE; Zhang X; Xie D; Hsu CY; Feldman HI; Coresh J; Vasan RS; Kimmel PL; Liu KD;
Diabetologia; 2015 Jan; 58(1):188-98. PubMed ID: 25316431
[TBL] [Abstract][Full Text] [Related]
9. Urinary Kidney Injury Molecules in Children with Iron-Deficiency Anemia.
Güneş A; Ece A; Aktar F; Tan İ; Söker M; Karabel D; Balık H; Uluca Ü; Şen V; Yolbaş İ
Med Sci Monit; 2015 Dec; 21():4023-9. PubMed ID: 26697893
[TBL] [Abstract][Full Text] [Related]
10. Establishment of reference values for novel urinary biomarkers for renal damage in the healthy population: are age and gender an issue?
Pennemans V; Rigo JM; Faes C; Reynders C; Penders J; Swennen Q
Clin Chem Lab Med; 2013 Sep; 51(9):1795-802. PubMed ID: 23648635
[TBL] [Abstract][Full Text] [Related]
11. Glomerular and tubular damage markers are elevated in patients with diabetes.
Nauta FL; Boertien WE; Bakker SJ; van Goor H; van Oeveren W; de Jong PE; Bilo H; Gansevoort RT
Diabetes Care; 2011 Apr; 34(4):975-81. PubMed ID: 21307379
[TBL] [Abstract][Full Text] [Related]
12. Urinary KIM-1, NGAL and L-FABP for the diagnosis of AKI in patients with acute coronary syndrome or heart failure undergoing coronary angiography.
Torregrosa I; Montoliu C; Urios A; Andrés-Costa MJ; Giménez-Garzó C; Juan I; Puchades MJ; Blasco ML; Carratalá A; Sanjuán R; Miguel A
Heart Vessels; 2015 Nov; 30(6):703-11. PubMed ID: 24989970
[TBL] [Abstract][Full Text] [Related]
13. NGAL (neutrophil gelatinase-associated lipocalin) and L-FABP after percutaneous coronary interventions due to unstable angina in patients with normal serum creatinine.
Bachorzewska-Gajewska H; Poniatowski B; Dobrzycki S
Adv Med Sci; 2009; 54(2):221-4. PubMed ID: 19875355
[TBL] [Abstract][Full Text] [Related]
14. Assessment of kidney function in diabetic patients. Is there a role for new biomarkers NGAL, cystatin C and KIM-1?
Matys U; Bachorzewska-Gajewska H; Malyszko J; Dobrzycki S
Adv Med Sci; 2013; 58(2):353-61. PubMed ID: 24384771
[TBL] [Abstract][Full Text] [Related]
15. Urinary L-FABP and its combination with urinary NGAL in early diagnosis of acute kidney injury after cardiac surgery in adult patients.
Liu S; Che M; Xue S; Xie B; Zhu M; Lu R; Zhang W; Qian J; Yan Y
Biomarkers; 2013 Feb; 18(1):95-101. PubMed ID: 23167703
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic performance of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for acute kidney injury in an obstructive nephropathy patient.
Xue W; Xie Y; Wang Q; Xu W; Mou S; Ni Z
Nephrology (Carlton); 2014 Apr; 19(4):186-94. PubMed ID: 24165570
[TBL] [Abstract][Full Text] [Related]
17. Effect of long-term storage of urine samples on measurement of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL).
van de Vrie M; Deegens JK; van der Vlag J; Hilbrands LB
Am J Kidney Dis; 2014 Apr; 63(4):573-6. PubMed ID: 24268306
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil gelatinase-associated lipocalin and liver-type fatty acid-binding protein as biomarkers for acute kidney injury after organ transplantation.
Iguchi N; Uchiyama A; Ueta K; Sawa Y; Fujino Y
J Anesth; 2015 Apr; 29(2):249-55. PubMed ID: 25205293
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers of acute kidney injury in pediatric cardiac surgery.
Peco-Antić A; Ivanišević I; Vulićević I; Kotur-Stevuljević J; Ilić S; Ivanišević J; Miljković M; Kocev N
Clin Biochem; 2013 Sep; 46(13-14):1244-51. PubMed ID: 23876402
[TBL] [Abstract][Full Text] [Related]
20. Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients.
Kim SS; Song SH; Kim IJ; Yang JY; Lee JG; Kwak IS; Kim YK
Diabetes Res Clin Pract; 2012 Aug; 97(2):251-7. PubMed ID: 22440044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
